Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
TEVA case study final
Teva Pharmaceutical Industries Ltd
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva Pharmaceuticals to Pay $225M to Texas to Settle Opioid Epidemic Claims - Top Class Actions
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.